Cargando…
Peroxoniobium inhibits leukemia cell growth
A new class of polyoxoniobate complex has been synthesized and characterized as a novel anticancer agent for photodynamic therapy. The complex inhibits the growth of chronic myelogenous leukemia cells with an IC(50) value of 30 μM, in the dark. However, upon exposure to light (365 nm) there is a fiv...
Autores principales: | Pereira-Maia, Elene C., Souza, Ivina P., Nunes, Kelen J. R. C., Castro, Alexandre A., Ramalho, Teodorico C., Steffler, Fernando, Duarte, Helio A., Pacheli, Ana, Chagas, Poliana, Oliveira, Luiz C. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9078932/ https://www.ncbi.nlm.nih.gov/pubmed/35540472 http://dx.doi.org/10.1039/c8ra00898a |
Ejemplares similares
-
New Heteroleptic Ruthenium(II) Complexes with Sulfamethoxypyridazine and Diimines as Potential Antitumor Agents
por: de Melo, Ariane C.C., et al.
Publicado: (2019) -
Understanding the Interaction Modes and Reactivity of Trimedoxime toward MmAChE Inhibited by Nerve Agents: Theoretical and Experimental Aspects
por: de Castro, Alexandre A., et al.
Publicado: (2020) -
First Attempts of the Use of (195)Pt NMR of Phenylbenzothiazole Complexes as Spectroscopic Technique for the Cancer Diagnosis
por: Pereira, Bruna T. L., et al.
Publicado: (2019) -
Future Therapeutic Perspectives into the Alzheimer’s Disease Targeting the Oxidative Stress Hypothesis
por: Teixeira, Jéssika P., et al.
Publicado: (2019) -
Computational evidence for nitro derivatives of quinoline and quinoline N-oxide as low-cost alternative for the treatment of SARS-CoV-2 infection
por: Assis, Letícia C., et al.
Publicado: (2021)